STAGE IA2 LUNG CANCER AJCC V8
Clinical trials for STAGE IA2 LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IA2 LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IA2 LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heat vs scalpel: new study tests better way to treat lung lesions
Disease control OngoingThis study compares two treatments for lung tumors: microwave ablation (using heat to kill cancer cells) and surgical wedge resection (removing a small piece of lung). It includes adults with non-small cell lung cancer, sarcoma, or colorectal cancer that has spread to the lungs. …
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Radiation booster targets lung tumors that came back
Disease control OngoingThis early-stage trial tests a drug called NBTXR3 that makes radiation more effective at killing cancer cells. It is for people with non-small cell lung cancer that has returned and cannot be removed with surgery. The study aims to find the safest dose and see if combining the dr…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
New combo therapy aims to boost lung cancer treatment without major surgery
Disease control OngoingThis study compares two treatments for early-stage non-small cell lung cancer: targeted radiation alone versus radiation plus the immunotherapy drug nivolumab. About 140 adults with stage I-IIA or recurrent lung cancer will participate. The goal is to see if adding immunotherapy …
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 13:34 UTC
-
New Self-Management program boosts cancer survivor care
Symptom relief OngoingThis study tests a telehealth program that coaches cancer survivors on managing their follow-up care after treatment. About 400 people who finished treatment for early-stage lung or colorectal cancer will participate. The goal is to improve their confidence, communication with do…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 17, 2026 01:47 UTC
-
New online program aims to ease emotional burden for women battling lung cancer
Symptom relief OngoingThis study tests an online program designed to help women with lung cancer feel more supported and less distressed during treatment. The program uses techniques like mindfulness and emotional processing to improve social well-being. About 70 women with stage I-IV non-small cell l…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Can we predict who will get nerve damage from chemo?
Knowledge-focused OngoingThis study aims to find out why some cancer patients develop nerve damage (tingling or numbness in hands and feet) from taxane chemotherapy. Researchers will track over 1,300 people with breast, lung, or ovarian cancer to see how age, gender, and other factors affect their risk. …
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:04 UTC